source
- T-Therapeutics secures $133M Series B to advance TCR-CD3 bispecifics with major pharma investorsT-Therapeutics announced a $133 million Series B financing round backed by several of the world’s largest drug developers, including Eli Lilly, Johnson & Johnson, Merck KGaA and Sanofi, along with…
- Medicare Part D premiums expected to rise 50% on average in 2027, KFF warns seniors to compare plansKFF analysis shows average monthly premiums for Medicare Part D standalone plans will jump from $34 to $51 in 2027, a 50% increase if seniors stay in their current plans. Premiums vary widely acro…